DeCure for Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation
DeCure's autonomous Cancer AI scientist is researching a drug-repurposing hypothesis for Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation — screening already-approved drugs against its 4-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleThyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation maps to a 4-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for thyroid gland spindle cell tumor with thymus-like differentiation is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
Molecular view
KRas proto-oncogene, GTPase (KRAS) — KRAS is one of the genes genetically linked to this disease in Open Targets — shown as context, not as a drug target we're pursuing: no approved-drug candidate for this disease is yet corroborated in the literature we found.
Loading structure…
helix sheet gnpdrag to rotate · scroll to zoom
RCSB Protein Data Bank · entry 7VVB · 1.7 Å · ligand PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER (GNP). Experimental structure, not a prediction.
What the evidence adds up to
Spindle epithelial tumor with thymus-like differentiation (SETTLE) of the thyroid is a rare neoplasm, with roughly 50 cases reported in the international literature as of 2022. It occurs predominantly in young patients and is considered a low-grade malignant tumor with indolent growth, but a tendency to develop delayed blood-borne metastases years after diagnosis. One 1999 case report describes a 29-year-old man whose tumor showed numerous mitotic figures and focal necrosis, features the authors note had not been previously reported and which they suggest may represent an aggressive variant. A 2010 report of two cases provided follow-up of 64 months and 30 months, respectively, without specifying recurrence or metastasis.
Diagnosis is frequently delayed. A 2021 case of a 7-year-old girl reports that fine needle aspiration cytology raised a differential of medullary thyroid carcinoma and small round blue cell tumour, and a definitive diagnosis of SETTLE was reached only after additional investigations and total thyroidectomy. The authors state that this diagnostic difficulty influenced choice of treatment. A 2022 case describes a 41-year-old man whose tumor occurred in the soft tissues of the neck around the thyroid, rather than within the gland itself. Immunohistochemistry showed CK and CK19 positivity in thymic epithelial components and CK, vimentin, and Bcl-2 positivity in spindle cells. This patient underwent mass resection, and no recurrence or metastasis was observed at 8 months postoperatively.
Surgical resection is reported as the main treatment option. No abstract mentions any drug therapy, chemotherapy, radiotherapy, or targeted agent being tested or used for SETTLE. No response rates, survival data from controlled studies, or comparisons between treatments are available in these reports. The evidence consists entirely of case reports and small case series.
What is missing is any clinical trial, any systematic collection of treatment outcomes across centres, any prospective registry, and any funding for such work. Because the tumour is so rare, no randomised or even large observational study exists to guide management beyond surgery. Patient stratification by mitotic activity, necrosis, or molecular markers has not been attempted in a formal study.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
The American Journal of Surgical Pathology · 1999 · 46 citations
Spindle Epithelial Tumor With Thymus-like Differentiation (SETTLE) of the Thyroid With Prominent Mitotic Activity and Focal Necrosis
AbstractSpindle epithelial tumor with thymus-like differentiation (SETTLE) is a rare, apparently low-grade spindle cell tumor of the thyroid gland occurring in young individuals and thought to be derived from thymic or branchial pouch remnants. Spindle epithelial tumor with thymus-like differentiation has little to no mitotic activity, and focal necrosis has been reported in one case. We present a case of SETTLE in a 29-year-old man that was initially evaluated by fine-needle aspirate biopsy and ultimately found to be consistent histologically with SETTLE. In this case, there were numerous mitotic figures among the spindle cells and focal necrosis. Spindle epithelial tumor with thymus-like differentiation has been considered to be a tumor of low malignant potential with metastases developing some years after diagnosis. This is the first case in which prominent mitotic activity and necrosis is reported perhaps representing an aggressive variant.
Indian Journal of Pathology and Microbiology · 2010 · 10 citations · open access
Spindle epithelial tumor with thymus-like differentiation of thyroid gland: Report of two cases with follow-up
AbstractSpindle epithelial tumor with thymus-like differentiation (SETTLE) is a rare malignant thyroid tumor showing thymic or related branchial pouch differentiation. The tumors are composed predominantly of spindle cells along with focal epithelial component and ductular formations. SETTLE occurs in young patients, with indolent growth and a tendency to develop delayed blood-borne metastases. We herein report two cases of SETTLE with a follow-up period of 64 months and 30 months, respectively.
Spindle cell tumour with thymus‐like differentiation (<scp>SETTLE</scp>) on fine needle aspiration cytology: A case report highlighting diagnostic pitfalls
AbstractA 7-year-old girl presented with a painless neck swelling localised near the left lobe of the thyroid gland, which was initially investigated by fine needle aspiration cytology. This raised a differential diagnosis of medullary thyroid carcinoma and small round blue cell tumour. Only after several additional clinical investigations and a total thyroidectomy was a definitive diagnosis of spindle cell tumour with thymus-like differentiation (SETTLE) reached. This case report highlights how contemporaneous clinical and investigation findings made arriving at a definitive diagnosis challenging, contributed to diagnostic delay, and ultimately influenced choice of treatment.
Oncology and Translational Medicine · 2022 · 2 citations · open access
Spindle epithelial tumor with thymus-like differentiation: A case report and literature review*
AbstractAbstract Spindle epithelial tumor with thymus-like differentiation (SETTLE) is a rare, low-grade malignant neoplasm that mainly occurs in the thyroid gland or its perimeter. Fewer than 10 cases of SETTLE have been reported in the Chinese literature, whereas approximately 50 cases have been reported in the international literature. We report a rare case of SETTLE that occurred in the soft tissues of the neck around the thyroid gland in a 41-year-old man. The neoplastic tissue, which mainly consisted of spindle epithelial components, included sporadically visible thymus-like structures. Immunohistochemistry demonstrated CK and CK19 positivity in the thymic epithelial components and CK, vimentin, and Bcl-2 positivity in the spindle cells. Surgical resection is the main treatment option for SETTLE. This patient underwent mass resection of the neck, and no recurrence or metastasis was observed even at 8 months postoperatively.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
